Beranda › Alopecia Areata › Texas
Uji klinis Alopecia Areata di Texas
7 studi untuk Alopecia Areata mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- 3A Research - East location /ID# 283404, El Paso
- Texas Dermatology and Laser Specialists /ID# 282813, San Antonio
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio
Menerima pesertaFase 2
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- The University of Texas Health Science Center at Houston, Bellaire
- Center for Clinical Studies, Houston
- Center for Clinical Studies - Clear Lake, Webster
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06873945A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Center for Clinical Studies, LTD. LLP, Houston
- Texas Dermatology and Laser Specialists, San Antonio
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Arlington Research Center, Inc /ID# 258028, Arlington
- Bellaire Dermatology Associates /ID# 259360, Bellaire
- Dfw Clinical Trials /ID# 284604, Carrollton
- dan 5 lainnya
Menerima pesertaFase 3
Usia 12 hingga 63 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- 3A Research, El Paso
- Texas Dermatology and Laser Specialists, San Antonio
Menerima pesertaFase 3
Usia 6 hingga 14 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatology Treatment And Research Center - Dallas, Dallas
- North Texas Center For Clinical Research, Frisco
- Austin Institute For Clinical Research Inc., Pflugerville
- dan 1 lainnya
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT07133308Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.